BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37976597)

  • 1. In vitro and in vivo killing effects of methionine enkephalin on osteosarcoma.
    Huang H; Wang X; Zhang S; Bai X; Griffin N; Shan Y; Shan F
    Int Immunopharmacol; 2023 Dec; 125(Pt B):111226. PubMed ID: 37976597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory role of methionine enkephalin in myeloid-derived suppressor cells and macrophages in human cutaneous squamous cell carcinoma.
    Bai X; Shan F; Qu N; Huang H; Handley M; Griffin N; Zhang S; Cao X
    Int Immunopharmacol; 2021 Oct; 99():107996. PubMed ID: 34311187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The novel mechanism of anticancer effect on gastric cancer through inducing G0/G1 cell cycle arrest and caspase-dependent apoptosis in vitro and in vivo by methionine enkephalin.
    Wang X; Tian J; Jiao X; Geng J; Wang R; Liu N; Gao X; Griffin N; Gao Y; Shan F
    Cancer Manag Res; 2018; 10():4773-4787. PubMed ID: 30425572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methionine enkephalin (MENK) suppresses lung cancer by regulating the Bcl-2/Bax/caspase-3 signaling pathway and enhancing natural killer cell-driven tumor immunity.
    Zhang S; Liu N; Ma M; Huang H; Handley M; Bai X; Shan F
    Int Immunopharmacol; 2021 Sep; 98():107837. PubMed ID: 34116288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methionine enkephalin (MENK) inhibits human gastric cancer through regulating tumor associated macrophages (TAMs) and PI3K/AKT/mTOR signaling pathway inside cancer cells.
    Wang X; Jiao X; Meng Y; Chen H; Griffin N; Gao X; Shan F
    Int Immunopharmacol; 2018 Dec; 65():312-322. PubMed ID: 30343258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methionine enkephalin inhibits colorectal cancer by remodeling the immune status of the tumor microenvironment.
    Wang X; Li S; Yan S; Shan Y; Wang X; Jingbo Z; Wang Y; Shan F; Griffin N; Sun X
    Int Immunopharmacol; 2022 Oct; 111():109125. PubMed ID: 35988519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel mechanism of lung cancer inhibition by methionine enkephalin through remodeling the immune status of the tumor microenvironment.
    Zhang S; Huang H; Handley M; Griffin N; Bai X; Shan F
    Int Immunopharmacol; 2021 Oct; 99():107999. PubMed ID: 34315116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage polarization induced by neuropeptide methionine enkephalin (MENK) promotes tumoricidal responses.
    Chen W; Liu J; Meng J; Lu C; Li X; Wang E; Shan F
    Cancer Immunol Immunother; 2012 Oct; 61(10):1755-68. PubMed ID: 22419372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Killing effect of methionine enkephalin on melanoma in vivo and in vitro.
    Wang DM; Jiao X; Plotnikoff NP; Griffin N; Qi RQ; Gao XH; Shan FP
    Oncol Rep; 2017 Oct; 38(4):2132-2140. PubMed ID: 28849104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methionine enkephalin suppresses lung cancer metastasis by regulating the polarization of tumor-associated macrophages and the distribution of myeloid-derived suppressor cells in the tumor microenvironment and inhibiting epithelial-mesenchymal transition.
    Zhang S; Geng J; Shan F; Shan Y; Griffin N; Wu B; Wang X
    Int Immunopharmacol; 2023 May; 118():110064. PubMed ID: 36989897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-inflammatory and metabolic reprogramming effects of MENK produce antitumor response in CT26 tumor-bearing mice.
    Tuo Y; Zhang Z; Tian C; Hu Q; Xie R; Yang J; Zhou H; Lu L; Xiang M
    J Leukoc Biol; 2020 Jul; 108(1):215-228. PubMed ID: 31994797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methionine enkephalin (MENK) inhibits tumor growth through regulating CD4+Foxp3+ regulatory T cells (Tregs) in mice.
    Li X; Meng Y; Plotnikoff NP; Youkilis G; Griffin N; Wang E; Lu C; Shan F
    Cancer Biol Ther; 2015; 16(3):450-9. PubMed ID: 25701137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel modulation on myeloid-derived suppressor cells (MDSCs) by methionine encephalin (MENK).
    Geng J; Yuan Y; Jiao X; Wang R; Liu N; Chen H; Griffin N; Shan F
    Int Immunopharmacol; 2019 Mar; 68():193-203. PubMed ID: 30654309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NFAT-1 hyper-activation by methionine enkephalin (MENK) significantly induces cell apoptosis of rats C6 glioma in vivo and in vitro.
    Lu WC; Xie H; Tie XX; Wang R; Wu AH; Shan FP
    Int Immunopharmacol; 2018 Mar; 56():1-8. PubMed ID: 29324390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiproperty Polyethylenimine-Caged Platinum Nanoclusters Promote Apoptosis of Osteosarcoma Cells via Regulating the BAX-Bcl-2/Caspase-3/PARP Axis.
    Wang J; Zhang M; Huang X; Yue H
    Mol Pharm; 2023 Nov; 20(11):5607-5615. PubMed ID: 37831437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methionine enkephalin (MENK) mounts antitumor effect via regulating dendritic cells (DCs).
    Meng Y; Gao X; Chen W; Plotnikoff NP; Griffin N; Zhang G; Shan F
    Int Immunopharmacol; 2017 Mar; 44():61-71. PubMed ID: 28088065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methionine enkephalin inhibited cervical carcinoma via apoptosis promotion and reduction of myeloid derived suppressor cell infiltrated in tumor.
    Qu N; Wang R; Meng Y; Liu N; Zhai J; Shan F
    Int Immunopharmacol; 2022 Sep; 110():108933. PubMed ID: 35738090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy of cancer via mediation of cytotoxic T lymphocytes by methionine enkephalin (MENK).
    Li W; Chen W; Herberman RB; Plotnikoff NP; Youkilis G; Griffin N; Wang E; Lu C; Shan F
    Cancer Lett; 2014 Mar; 344(2):212-22. PubMed ID: 24291668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction on differentiation and modulation of bone marrow progenitor of dendritic cell by methionine enkephalin (MENK).
    Liu J; Chen W; Meng J; Lu C; Wang E; Shan F
    Cancer Immunol Immunother; 2012 Oct; 61(10):1699-711. PubMed ID: 22392190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD10 enhances metastasis of colorectal cancer by abrogating the anti-tumoural effect of methionine-enkephalin in the liver.
    Kuniyasu H; Luo Y; Fujii K; Sasahira T; Moriwaka Y; Tatsumoto N; Sasaki T; Yamashita Y; Ohmori H
    Gut; 2010 Mar; 59(3):348-56. PubMed ID: 19828468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.